← back to search

Jian-Jun Wei

New York University · US
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research focused on Cancer research and Ovarian cancer, with related work in Metastasis, Cancer, Serous fluid. Notable publications include 'Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis', 'MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma', and 'miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma'.
h-index
citations
944
works
11
NIH funding
primary concept
email

Recent publications

Uterine fibroids
Physiological Reviews 2025cited by 20position: middledoi
A pan-cancer organoid platform for precision medicine
Cell Reports 2021cited by 96position: middledoi
Risk Factors for Different Types of Pregnancy Losses: Analysis of 15,210 Pregnancies After Embryo Transfer
Frontiers in Endocrinology 2021cited by 34position: middledoi
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Cancer Research 2020cited by 245position: middledoi
Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer
Redox Biology 2018cited by 88position: middledoi
PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
Oncogene 2018cited by 70position: middledoi
Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors
Frontiers in Oncology 2015cited by 23position: middledoi
MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma
Modern Pathology 2014cited by 170position: lastdoi
miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
Oncotarget 2014cited by 98position: middledoi
Anti- <i>miR182</i> Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An <i>In Vivo</i> Study in Orthotopic Xenografts of Nude Mice
Molecular Cancer Therapeutics 2014cited by 57position: lastdoi
<i>miR-106a</i> Represses the Rb Tumor Suppressor p130 to Regulate Cellular Proliferation and Differentiation in High-Grade Serous Ovarian Carcinoma
Molecular Cancer Research 2013cited by 43position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Zhaojian Liu · New York University4 papers (2013–2018)Changshun Shao · Changchun University of Science and Technology3 papers (2013–2018)Beihua Kong · New York University3 papers (2013–2014)Ruifen Dong · New York University2 papers (2013–2014)Xiuhua Xu · Fujian Medical University2 papers (2018–2021)Beihua Kong · Chinese Center For Disease Control and Prevention2 papers (2014–2018)Wenan Qiang · Northwestern University2 papers (2014–2014)Takeshi Kurita · Tokyo Medical and Dental University2 papers (2014–2014)Daniel D. Lantvit · University of Illinois Chicago2 papers (2015–2018)Joanna E. Burdette · University of Illinois Chicago2 papers (2015–2018)Jinsong Liu · Chongqing University of Posts and Telecommunications2 papers (2013–2014)David A. Davis · University of Illinois Chicago2 papers (2015–2018)Khush Mittal · New York University1 papers (2014–2014) · 1 papers (2014–2014)Yingwei Li · Shandong University1 papers (2014–2014)Angela Russo · University of Illinois Chicago1 papers (2018–2018)Eva Hernando · NYU Langone Health1 papers (2014–2014)Matthew Dean · University of Illinois Chicago1 papers (2018–2018) · 1 papers (2025–2025)Subbulakshmi Karthikeyan · Duke-NUS Medical School1 papers (2015–2015)